SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Exact Sciences Corp. – ‘8-K’ for 3/17/23

On:  Friday, 3/17/23, at 4:07pm ET   ·   For:  3/17/23   ·   Accession #:  1124140-23-36   ·   File #:  1-35092

Previous ‘8-K’:  ‘8-K’ on 3/3/23 for 3/2/23   ·   Next:  ‘8-K’ on / for 5/9/23   ·   Latest:  ‘8-K’ on / for 4/17/24   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/17/23  Exact Sciences Corp.              8-K:8,9     3/17/23   12:206K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     33K 
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     14K 
 7: R1          Cover Page                                          HTML     45K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- exas-20230317_htm                   XML     15K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.DEF  XBRL Definitions -- exas-20230317_def                XML     39K 
 5: EX-101.LAB  XBRL Labels -- exas-20230317_lab                     XML     80K 
 6: EX-101.PRE  XBRL Presentations -- exas-20230317_pre              XML     39K 
 3: EX-101.SCH  XBRL Schema -- exas-20230317                         XSD     11K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    20K 
12: ZIP         XBRL Zipped Folder -- 0001124140-23-000036-xbrl      Zip     22K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  exas-20230317  
 i 0001124140 i false00011241402023-03-172023-03-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM  i 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):   i March 17, 2023
 
 i EXACT SCIENCES CORPORATION
(Exact Name of Registrant as Specified in Charter)
 
 i Delaware  i 001-35092  i 02-0478229
(State or Other Jurisdiction
of Incorporation)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)
 
 i 5505 Endeavor Lane
 i Madison,  i WI   i 53719
(Address of Principal Executive Offices)(Zip Code)
 
Registrant’s telephone number, including area code:  ( i 608)  i 284-5700
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 i             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 i            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 i             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 i            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange
on which registered
 i Common Stock, $0.01 par value per share i EXAS i The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 8.01.                        Other Events.

On March 17, 2023, Exact Sciences Corporation (the “Company”) filed with the Securities and Exchange Commission, a prospectus supplement dated March 17, 2023 (the “Prospectus Supplement”) to the Company's automatic shelf registration statement on Form S-3 (Registration No. 333-238845). The Prospectus Supplement was filed to register the resale from time to time by the selling stockholders referenced in the Prospectus Supplement of up to 5,171,577 shares of the Company’s common stock, par value $0.01 per share.

In connection with the Prospectus Supplement, the Company is filing the opinion of its counsel, K&L Gates LLP, regarding the legality of the securities being registered, which opinion is attached as Exhibit 5.1 to this Current Report on Form 8-K.

Item 9.01.                     Financial Statements and Exhibits.
 
(d) Exhibits.   
Exhibit No. Exhibit Description
   
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
2


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 EXACT SCIENCES CORPORATION
   
Date: March 17, 2023By:/s/ Jeffrey T. Elliott
  Jeffrey T. Elliott
  Executive Vice President, Chief Financial Officer and Chief Operating Officer

3

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:3/17/23424B7
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/01/23  Exact Sciences Corp.              S-8         8/01/23    4:106K
 5/25/23  Exact Sciences Corp.              S-3ASR      5/25/23    6:771K
Top
Filing Submission 0001124140-23-000036   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 3:54:31.1am ET